Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells

Veterinary Immunology and Immunopathology

Volumn 126, Issue 1-2, 2008, Pages 43-53

  Ohmori, Keitaro ^a,b   Kawarai, Shinpei ^a   Yasuda, Nobutaka ^a   Tanaka, Akane ^b   Matsuda, Hiroshi ^b   Nishimura, Ryohei ^a   Sasaki, Nobuo ^a   Tsujimoto, Hajime ^a   Masuda, Kenichi ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tokyo University of Agriculture and Technology   (Japan)

^c Yokohama Institute   (Japan)

Author keywords

c kit; Dog; Mast cell tumor; Mutations

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIUM IONOPHORE; CHYMASE; FC RECEPTOR; GENOMIC DNA; HISTAMINE; IMATINIB; METHYLPREDNISOLONE; STEM CELL FACTOR; TRYPTASE; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DOG; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MALE; MASTOCYTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MAST CELLS; MASTOCYTOMA; MOLECULAR SEQUENCE DATA; MUTATION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES;

CANIS FAMILIARIS;

EID: 54349093009     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.06.014     Document Type: Article

References (27)

1. Akin C., and Metcalfe D.D. The biology of Kit in disease and the application of pharmacogenetics. The Journal of Allergy and Clinical Immunology 114 (2004) 13-19 quiz 20
2. Brazis P., Torres R., Queralt M., de Mora F., Ferrer L., and Puigdemont A. Evaluation of cell-surface IgE receptors on the canine mastocytoma cell line C2 maintained in continuous culture. American Journal of Veterinary Research 63 (2002) 763-766
3. Dalerba P., Cho R.W., and Clarke M.F. Cancer stem cells: models and concepts. Annual Review of Medicine 58 (2007) 267-284
4. Downing S., Chien M.B., Kass P.H., Moore P.E., and London C.A. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. American Journal of Veterinary Research 63 (2002) 1718-1723
5. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annual Review of Immunology 23 (2005) 749-786
6. Garcia G., Brazis P., Majo N., Ferrer L., de Mora F., and Puigdemont A. Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. Veterinary Immunology and Immunopathology 62 (1998) 323-337
7. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nature Review of Immunology 6 (2006) 218-230
8. Gould H.J., Sutton B.J., Beavil A.J., Beavil R.L., McCloskey N., Coker H.A., Fear D., and Smurthwaite L. The biology of IGE and the basis of allergic disease. Annual Review of Immunology 21 (2003) 579-628
9. Ishiguro T., Kadosawa T., Mori K., Takagi S., Okumura M., and Fujinaga T. Establishment and characterization of a new canine mast cell tumor cell line. The Journal of Veterinary Medical Science 63 (2001) 1031-1034
10. Kambe N., Kambe M., Kochan J.P., and Schwartz L.B. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97 (2001) 2045-2052
11. Liao A.T., Chien M.B., Shenoy N., Mendel D.B., McMahon G., Cherrington J.M., and London C.A. Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 100 (2002) 585-593
12. Lin T.Y., Rush L.J., and London C.A. Generation and characterization of bone marrow-derived cultured canine mast cells. Veterinary Immunology and Immunopathology 113 (2006) 37-52
13. London C.A., Galli S.J., Yuuki T., Hu Z.Q., Helfand S.C., and Geissler E.N. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Experimental Hematology 27 (1999) 689-697
14. London C.A., and Seguin B. Mast cell tumors in the dog. The Veterinary Clinics of North America: Small Animal Practice 33 (2003) 473-489 v
15. Ma Y., Longley B.J., Wang X., Blount J.L., Langley K., and Caughey G.H. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. The Journal of Investigative Dermatology 112 (1999) 165-170
16. Ma Y., Zeng S., Metcalfe D.D., Akin C., Dimitrijevic S., Butterfield J.H., McMahon G., and Longley B.J. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99 (2002) 1741-1744
17. Momoi Y., Okai Y., Watari T., Goitsuka R., Tsujimoto H., and Hasegawa A. Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Veterinary Immunology and Immunopathology 59 (1997) 11-20
18. Ohmori K., Maeda S., Okayama T., Masuda K., Ohno K., and Tsujimoto H. Molecular cloning of canine activation-induced cytidine deaminase (AID) cDNA and its expression in normal tissues. The Journal of Veterinary Medical Science 66 (2004) 739-741
19. Patnaik A.K., Ehler W.J., and MacEwen E.G. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 21 (1984) 469-474
20. Pryer N.K., Lee L.B., Zadovaskaya R., Yu X., Sukbuntherng J., Cherrington J.M., and London C.A. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. Clinical Cancer Research 9 (2003) 5729-5734
21. Roskoski Jr. R. Signaling by Kit protein-tyrosine kinase-the stem cell factor receptor. Biochemical and Biophysical Research Communications 337 (2005) 1-13
22. Roskoski Jr. R. Structure and regulation of Kit protein-tyrosine kinase-the stem cell factor receptor. Biochemical and Biophysical Research Communications 338 (2005) 1307-1315
23. Takahashi T., Kitani S., Nagase M., Mochizuki M., Nishimura R., Morita Y., and Sasaki N. IgG-mediated histamine release from canine mastocytoma-derived cells. International Archives of Allergy and Immunology 125 (2001) 228-235
24. Tsai K.L., Guyon R., and Murphy K.E. Identification of isoforms and RH mapping of canine KIT. Cytogenetic and Genome Research 102 (2003) 261-263
25. Yarden Y., Kuang W.J., Yang-Feng T., Coussens L., Munemitsu S., Dull T.J., Chen E., Schlessinger J., Francke U., and Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. The EMBO Journal 6 (1987) 3341-3351
26. Zemke D., Yamini B., and Yuzbasiyan-Gurkan V. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Veterinary Pathology 39 (2002) 529-535
27. Zermati Y., De Sepulveda P., Feger F., Letard S., Kersual J., Casteran N., Gorochov G., Dy M., Ribadeau Dumas A., Dorgham K., Parizot C., Bieche Y., Vidaud M., Lortholary O., Arock M., Hermine O., and Dubreuil P. Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene 22 (2003) 660-664